{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:43:50Z","timestamp":1794638630309,"version":"4.9.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100019921","name":"National Scleroderma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL172830-01"],"award-info":[{"award-number":["1R01HL172830-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL162851"],"award-info":[{"award-number":["R01HL162851"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR191839"],"award-info":[{"award-number":["PR191839"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR231648"],"award-info":[{"award-number":["PR231648"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K24080217"],"award-info":[{"award-number":["K24080217"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11886-024-02164-w","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T04:37:48Z","timestamp":1735965468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications"],"prefix":"10.1007","volume":"27","author":[{"given":"Ryan","family":"Osgueritchian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Mombeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek P.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Hummers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick M.","family":"Wigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"2164_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11926-019-0867-0","volume":"21","author":"G Hung","year":"2019","unstructured":"Hung G, Mercurio V, Hsu S, Mathai SC, Shah AA, Mukherjee M. Progress in understanding, diagnosing, and managing cardiac complications of systemic sclerosis. Curr Rheumatol Rep. 2019;21:68.","journal-title":"Curr Rheumatol Rep"},{"key":"2164_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ccl.2021.08.003","volume":"40","author":"SC Mathai","year":"2022","unstructured":"Mathai SC. Pulmonary Hypertension Associated with connective tissue disease. Cardiol Clin. 2022;40:29\u201343. https:\/\/doi.org\/10.1016\/j.ccl.2021.08.003.","journal-title":"Cardiol Clin"},{"key":"2164_CR3","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/art.22747","volume":"56","author":"A Perera","year":"2007","unstructured":"Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA Jr. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum. 2007;56:2740\u20136. https:\/\/doi.org\/10.1002\/art.22747.","journal-title":"Arthritis Rheum"},{"key":"2164_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/23971983231163413","volume":"8","author":"C Bruni","year":"2023","unstructured":"Bruni C, Buch MH, Djokovic A, De Luca G, Dumitru RB, Giollo A, Galetti I, Steelandt A, Bratis K, Suliman YA, et al. Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation\/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment. J Scleroderma Relat Disord. 2023;8:169\u201382. https:\/\/doi.org\/10.1177\/23971983231163413.","journal-title":"J Scleroderma Relat Disord"},{"key":"2164_CR5","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1161\/circulationaha.117.033147","volume":"137","author":"S Hsu","year":"2018","unstructured":"Hsu S, Kokkonen-Simon KM, Kirk JA, Kolb TM, Damico RL, Mathai SC, Mukherjee M, Shah AA, Wigley FM, Margulies KB, et al. Right ventricular myofilament functional differences in humans with systemic sclerosis-Associated Versus Idiopathic Pulmonary arterial hypertension. Circulation. 2018;137:2360\u201370. https:\/\/doi.org\/10.1161\/circulationaha.117.033147.","journal-title":"Circulation"},{"key":"2164_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020;8:304\u201320. https:\/\/doi.org\/10.1016\/S2213-2600(19)30480-1.","journal-title":"Lancet Respir Med"},{"key":"2164_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5414\/CN111243","volume":"102","author":"L Farrukh","year":"2024","unstructured":"Farrukh L, Steen V, Shapiro L, Faddoul G, Mehta S. Spectrum of renal disease in scleroderma other than scleroderma renal crisis: a review of the literature. Clin Nephrol. 2024;102:97\u2013106. https:\/\/doi.org\/10.5414\/CN111243.","journal-title":"Clin Nephrol"},{"key":"2164_CR8","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airo P, Joven B, Vettori S, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76:1897\u2013905. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211448.","journal-title":"Ann Rheum Dis"},{"key":"2164_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/23971983211053246","volume":"7","author":"C Bruni","year":"2022","unstructured":"Bruni C, Buch MH, Furst DE, De Luca G, Djokovic A, Dumitru RB, Giollo A, Polovina M, Steelandt A, Bratis K, et al. Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF\/HFA definition. J Scleroderma Relat Disord. 2022;7:24\u201332. https:\/\/doi.org\/10.1177\/23971983211053246.","journal-title":"J Scleroderma Relat Disord"},{"key":"2164_CR10","doi-asserted-by":"publisher","first-page":"152229","DOI":"10.1016\/j.semarthrit.2023.152229","volume":"62","author":"JL Fairley","year":"2023","unstructured":"Fairley JL, Ross L, Quinlivan A, Hansen D, Paratz E, Stevens W, Kistler PM, McLellan A, La Gerche A, Nikpour M. Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2023;62:152229. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152229.","journal-title":"Semin Arthritis Rheum"},{"key":"2164_CR11","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1093\/rheumatology\/keaa742","volume":"60","author":"RB Dumitru","year":"2021","unstructured":"Dumitru RB, Bissell LA, Erhayiem B, Fent G, Kidambi A, Swoboda P, Abignano G, Donica H, Burska A, Greenwood JP, et al. Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis. Rheumatology (Oxford). 2021;60:2934\u201345. https:\/\/doi.org\/10.1093\/rheumatology\/keaa742.","journal-title":"Rheumatology (Oxford)"},{"key":"2164_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12016-022-08946-w","volume":"64","author":"I Cavazzana","year":"2023","unstructured":"Cavazzana I, Vojinovic T, Airo P, Fredi M, Ceribelli A, Pedretti E, Lazzaroni MG, Garrafa E, Franceschini F. Systemic sclerosis-specific antibodies: Novel and classical biomarkers. Clin Rev Allergy Immunol. 2023;64:412\u201330. https:\/\/doi.org\/10.1007\/s12016-022-08946-w.","journal-title":"Clin Rev Allergy Immunol"},{"key":"2164_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/BOR.0000000000000966","volume":"35","author":"CM Connolly","year":"2023","unstructured":"Connolly CM, Paik JJ. Myopathy in systemic sclerosis. Curr Opin Rheumatol. 2023;35:341\u20138. https:\/\/doi.org\/10.1097\/BOR.0000000000000966.","journal-title":"Curr Opin Rheumatol"},{"key":"2164_CR14","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.55563\/clinexprheumatol\/fytfmy","volume":"40","author":"JJ Paik","year":"2022","unstructured":"Paik JJ, Choi DY, Mukherjee M, Hsu S, Wigley F, Shah AA, Hummers LK. Troponin elevation independently associates with mortality in systemic sclerosis. Clin Exp Rheumatol. 2022;40:1933\u201340. https:\/\/doi.org\/10.55563\/clinexprheumatol\/fytfmy.","journal-title":"Clin Exp Rheumatol"},{"key":"2164_CR15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/acr.22547","volume":"67","author":"J Avouac","year":"2015","unstructured":"Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide. Arthritis Care Res (Hoboken). 2015;67:1022\u201330. https:\/\/doi.org\/10.1002\/acr.22547.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2164_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijcard.2016.08.246","volume":"223","author":"Y Allanore","year":"2016","unstructured":"Allanore Y, Komocsi A, Vettori S, Hachulla E, Hunzelmann N, Distler J, Avouac J, Gobeaux C, Launay D, Czirjak L, et al. N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis. Int J Cardiol. 2016;223:385\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.246.","journal-title":"Int J Cardiol"},{"key":"2164_CR17","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/acr.23861","volume":"71","author":"DF Moore","year":"2019","unstructured":"Moore DF, Kramer E, Eltaraboulsi R, Steen VD. Increased morbidity and mortality of Scleroderma in African americans compared to non-african americans. Arthritis Care Res (Hoboken). 2019;71:1154\u201363. https:\/\/doi.org\/10.1002\/acr.23861.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2164_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1253\/circj.CJ-14-1114","volume":"79","author":"A Faccini","year":"2015","unstructured":"Faccini A, Agricola E, Oppizzi M, Margonato A, Galderisi M, Sabbadini MG, Franchini S, Camici PG. Coronary microvascular dysfunction in asymptomatic patients affected by systemic sclerosis - limited vs. diffuse form. Circ J. 2015;79:825\u20139. https:\/\/doi.org\/10.1253\/circj.CJ-14-1114.","journal-title":"Circ J"},{"key":"2164_CR19","first-page":"S48","volume":"28","author":"Y Allanore","year":"2010","unstructured":"Allanore Y, Meune C. Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin. Clin Exp Rheumatol. 2010;28:S48\u201353.","journal-title":"Clin Exp Rheumatol"},{"key":"2164_CR20","doi-asserted-by":"publisher","first-page":"152033","DOI":"10.1016\/j.semarthrit.2022.152033","volume":"55","author":"A Gonzalez Garcia","year":"2022","unstructured":"Gonzalez Garcia A, Fabregate M, Manzano L, Guillen Del Castillo A, Rubio Rivas M, Argibay A, Marin Ballve A, Rodriguez Pinto I, Pla Salas X, Mari-Alfonso B, et al. Left ventricular diastolic dysfunction in systemic sclerosis: clinical, immunological and survival differences in the Spanish RESCLE registry. Semin Arthritis Rheum. 2022;55:152033. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152033.","journal-title":"Semin Arthritis Rheum"},{"key":"2164_CR21","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/ehjci\/jeae001","volume":"25","author":"JL Vos","year":"2024","unstructured":"Vos JL, Lemmers JMJ, El Messaoudi S, Snoeren M, van Dijk APJ, Duijnhouwer AL, Rodwell L, van Leuven SI, Post MC, Vonk MC, et al. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension. Eur Heart J Cardiovasc Imaging. 2024;25:708\u201317. https:\/\/doi.org\/10.1093\/ehjci\/jeae001.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2164_CR22","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.jacc.2023.09.819","volume":"82","author":"BN Weber","year":"2023","unstructured":"Weber BN, Paik JJ, Aghayev A, Klein AL, Mavrogeni SI, Yu PB, Mukherjee M. Novel imaging approaches to Cardiac manifestations of systemic inflammatory diseases: JACC Scientific Statement. J Am Coll Cardiol. 2023;82:2128\u201351. https:\/\/doi.org\/10.1016\/j.jacc.2023.09.819.","journal-title":"J Am Coll Cardiol"},{"key":"2164_CR23","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1093\/ehjci\/jeac134","volume":"23","author":"S Mavrogeni","year":"2022","unstructured":"Mavrogeni S, Pepe A, Nijveldt R, Ntusi N, Sierra-Galan LM, Bratis K, Wei J, Mukherjee M, Markousis-Mavrogenis G, Gargani L, et al. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022;23:e308\u201322. https:\/\/doi.org\/10.1093\/ehjci\/jeac134.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2164_CR24","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/rheumatology\/kez658","volume":"59","author":"G De Luca","year":"2020","unstructured":"De Luca G, Campochiaro C, De Santis M, Sartorelli S, Peretto G, Sala S, Canestrari G, De Lorenzis E, Basso C, Rizzo S, et al. Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. Rheumatology (Oxford). 2020;59:2523\u201333. https:\/\/doi.org\/10.1093\/rheumatology\/kez658.","journal-title":"Rheumatology (Oxford)"},{"key":"2164_CR25","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00259-022-06081-4","volume":"50","author":"C Treutlein","year":"2023","unstructured":"Treutlein C, Distler JHW, Tascilar K, Fakhouri SC, Gyorfi AH, Atzinger A, Matei AE, Dees C, Buttner-Herold M, Kuwert T, et al. Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT. Eur J Nucl Med Mol Imaging. 2023;50:1629\u201335. https:\/\/doi.org\/10.1007\/s00259-022-06081-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2164_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3899\/jrheum.2023-0801","volume":"51","author":"JL Fairley","year":"2024","unstructured":"Fairley JL, Hansen D, Burns A, Prior D, La Gerche A, Morrisroe K, Stevens W, Nikpour M, Ross LJ. Contribution of left ventricular diastolic dysfunction to survival and breathlessness in systemic sclerosis-Associated interstitial lung disease. J Rheumatol. 2024;51:495\u2013504. https:\/\/doi.org\/10.3899\/jrheum.2023-0801.","journal-title":"J Rheumatol"},{"key":"2164_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.10.013","author":"S Bosello","year":"2018","unstructured":"Bosello S, De Luca G, Berardi G, Canestrari G, de Waure C, Gabrielli FA, Di Mario C, Forni F, Gremese E, Ferraccioli G. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: a prospective study. Eur J Intern Med. 2018. https:\/\/doi.org\/10.1016\/j.ejim.2018.10.013.","journal-title":"Eur J Intern Med"},{"key":"2164_CR28","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/rheumatology\/kew364","volume":"56","author":"LA Bissell","year":"2017","unstructured":"Bissell LA, Md Yusof MY, Buch MH. Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK systemic sclerosis Study Group cardiac working group. Rheumatology (Oxford). 2017;56:882\u201395. https:\/\/doi.org\/10.1093\/rheumatology\/kew364.","journal-title":"Rheumatology (Oxford)"},{"key":"2164_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1183\/09031936.00074309","volume":"35","author":"SC Mathai","year":"2010","unstructured":"Mathai SC, Bueso M, Hummers LK, Boyce D, Lechtzin N, Le Pavec J, Campo A, Champion HC, Housten T, Forfia PR, et al. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. Eur Respir J. 2010;35:95\u2013104. https:\/\/doi.org\/10.1183\/09031936.00074309.","journal-title":"Eur Respir J"},{"key":"2164_CR30","first-page":"S81","volume":"30","author":"C Chighizola","year":"2012","unstructured":"Chighizola C, Meroni PL, Schreiber BE, Coghlan JG, Denton CP, Ong VH. Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients. Clin Exp Rheumatol. 2012;30:S81\u201385.","journal-title":"Clin Exp Rheumatol"},{"key":"2164_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.semarthrit.2020.10.016","volume":"51","author":"L Ross","year":"2021","unstructured":"Ross L, Moxey J, Nikpour M. Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review. Semin Arthritis Rheum. 2021;51:299\u2013309. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.10.016.","journal-title":"Semin Arthritis Rheum"},{"key":"2164_CR32","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1038\/s41467-023-41117-9","volume":"14","author":"C Ortega-Ferreira","year":"2023","unstructured":"Ortega-Ferreira C, Soret P, Robin G, Speca S, Hubert S, Le Gall M, Desvaux E, Jendoubi M, Saint-Paul J, Chadli L, et al. Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis. Nat Commun. 2023;14:5291. https:\/\/doi.org\/10.1038\/s41467-023-41117-9.","journal-title":"Nat Commun"},{"key":"2164_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ijcard.2017.08.072","volume":"249","author":"M Hromadka","year":"2017","unstructured":"Hromadka M, Seidlerova J, Suchy D, Rajdl D, Lhotsky J, Ludvik J, Rokyta R, Baxa J. Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - relationship with biochemical and echocardiography parameters. Int J Cardiol. 2017;249:448\u201353. https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.072.","journal-title":"Int J Cardiol"},{"key":"2164_CR34","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/rheumatology\/kew488","volume":"56","author":"LA Bissell","year":"2017","unstructured":"Bissell LA, Anderson M, Burgess M, Chakravarty K, Coghlan G, Dumitru RB, Graham L, Ong V, Pauling JD, Plein S, et al. Consensus best practice pathway of the UK systemic sclerosis study group: management of cardiac disease in systemic sclerosis. Rheumatology (Oxford). 2017;56:912\u201321. https:\/\/doi.org\/10.1093\/rheumatology\/kew488.","journal-title":"Rheumatology (Oxford)"},{"key":"2164_CR35","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1093\/rheumatology\/keae199","volume":"63","author":"A Bhalodia","year":"2024","unstructured":"Bhalodia A, Bermea K, Schmidt J, Gilotra N, Barth AS, Adamo L, Paik JJ. Increased risk of myocarditis and arrythmias in anti-ku-positive scleroderma-myositis overlap patients: a case series. Rheumatology (Oxford). 2024;63:e268\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keae199.","journal-title":"Rheumatology (Oxford)"},{"key":"2164_CR36","doi-asserted-by":"publisher","unstructured":"Hoffmann-Vold AM, Distler O, Murray B, Kowal-Bielecka O, Khanna D, Allanore Y, Eustar S. Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features. RMD Open. 2019;5:e000826. https:\/\/doi.org\/10.1136\/rmdopen-2018-000826","DOI":"10.1136\/rmdopen-2018-000826"},{"key":"2164_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/art.42054","volume":"74","author":"AM Hinze","year":"2022","unstructured":"Hinze AM, Perin J, Woods A, Hummers LK, Wigley FM, Mukherjee M, Shah AA. Diastolic dysfunction in systemic sclerosis: risk factors and impact on Mortality. Arthritis Rheumatol. 2022;74:849\u201359. https:\/\/doi.org\/10.1002\/art.42054.","journal-title":"Arthritis Rheumatol"},{"key":"2164_CR38","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3899\/jrheum.200873","volume":"48","author":"V Mercurio","year":"2021","unstructured":"Mercurio V, Hinze AM, Hummers LK, Wigley FM, Shah AA, Mukherjee M. Essential hypertension worsens left ventricular contractility in systemic sclerosis. J Rheumatol. 2021;48:1299\u2013306. https:\/\/doi.org\/10.3899\/jrheum.200873.","journal-title":"J Rheumatol"},{"key":"2164_CR39","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.jacc.2018.07.068","volume":"72","author":"AH Tenn\u00f8e","year":"2018","unstructured":"Tenn\u00f8e AH, Murbr\u00e6ch K, Andreassen JC, Fretheim H, Garen T, Gude E, Andreassen A, Aakhus S, Molberg \u00d8, Hoffmann-Vold A-M. Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis. J Am Coll Cardiol. 2018;72:1804\u201313.","journal-title":"J Am Coll Cardiol"},{"key":"2164_CR40","doi-asserted-by":"publisher","first-page":"e017074","DOI":"10.1161\/CIRCIMAGING.124.017074","volume":"17","author":"M Mukherjee","year":"2024","unstructured":"Mukherjee M, Mathai SC, Jellis C, Freed BH, Yanek LR, Agoglia H, Chiu C, Jani VP, Simpson CE, Brittain EL, et al. Defining echocardiographic degrees of right heart size and function in Pulmonary Vascular Disease from the PVDOMICS study. Circ Cardiovasc Imaging. 2024;17:e017074. https:\/\/doi.org\/10.1161\/CIRCIMAGING.124.017074.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2164_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2024.09.010","author":"A Gami","year":"2024","unstructured":"Gami A, Jani VP, Mombeini H, Osgueritchian R, Cubero Salazar IM, Kauffman M, Simpson CE, Damico RL, Kolb TM, Shah AA, et al. Prognostic Value of Echocardiographic Coupling Metrics in systemic sclerosis-Associated Pulmonary Vascular Disease. J Am Soc Echocardiogr. 2024. https:\/\/doi.org\/10.1016\/j.echo.2024.09.010.","journal-title":"J Am Soc Echocardiogr"},{"key":"2164_CR42","doi-asserted-by":"publisher","first-page":"e12361","DOI":"10.1002\/pul2.12361","volume":"14","author":"BE Celestin","year":"2024","unstructured":"Celestin BE, Bagherzadeh SP, Ichimura K, Santana EJ, Sanchez PA, Tobore T, Hemnes AR, Vonk Noordegraaf A, Salerno M, Zamanian RT, et al. Identifying consistent echocardiographic thresholds for risk stratification in pulmonary arterial hypertension. Pulm Circ. 2024;14:e12361. https:\/\/doi.org\/10.1002\/pul2.12361.","journal-title":"Pulm Circ"},{"key":"2164_CR43","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Grunig E, Bonderman D, Distler O, Khanna D, Muller-Ladner U, Pope JE, Vonk MC, Doelberg M, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73:1340\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203301.","journal-title":"Ann Rheum Dis"},{"key":"2164_CR44","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"61","author":"M Humbert","year":"2023","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023;61:2200879. https:\/\/doi.org\/10.1183\/13993003.00879-2022.","journal-title":"Eur Respir J"},{"key":"2164_CR45","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.55563\/clinexprheumatol\/irc0ih","volume":"40","author":"L Ross","year":"2022","unstructured":"Ross L, Patel S, Stevens W, Burns A, Prior D, La Gerche A, Nikpour M. The clinical implications of left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol. 2022;40:1986\u201392. https:\/\/doi.org\/10.55563\/clinexprheumatol\/irc0ih.","journal-title":"Clin Exp Rheumatol"},{"key":"2164_CR46","doi-asserted-by":"publisher","first-page":"152443","DOI":"10.1016\/j.semarthrit.2024.152443","volume":"66","author":"JL Fairley","year":"2024","unstructured":"Fairley JL, Hansen D, Proudman S, Sahhar J, Ngian GS, Walker J, Host LV, La Gerche A, Prior D, Burns A, et al. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis. Semin Arthritis Rheum. 2024;66:152443. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152443.","journal-title":"Semin Arthritis Rheum"},{"key":"2164_CR47","doi-asserted-by":"publisher","first-page":"H1847","DOI":"10.1152\/ajpheart.00434.2006","volume":"292","author":"MR Bergman","year":"2007","unstructured":"Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, Dahi S, Karliner JS, Lovett DH. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol. 2007;292:H1847\u20131860. https:\/\/doi.org\/10.1152\/ajpheart.00434.2006.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2164_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcmg.2018.12.034","volume":"13","author":"M Obokata","year":"2020","unstructured":"Obokata M, Reddy YNV, Borlaug BA. Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods. JACC Cardiovasc Imaging. 2020;13:245\u201357. https:\/\/doi.org\/10.1016\/j.jcmg.2018.12.034.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2164_CR49","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/rheumatology\/keu350","volume":"54","author":"TS Rodriguez-Reyna","year":"2015","unstructured":"Rodriguez-Reyna TS, Morelos-Guzman M, Hernandez-Reyes P, Montero-Duarte K, Martinez-Reyes C, Reyes-Utrera C, Vazquez-La Madrid J, Morales-Blanhir J, Nunez-Alvarez C, Cabiedes-Contreras J. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology (Oxford). 2015;54:647\u201354. https:\/\/doi.org\/10.1093\/rheumatology\/keu350.","journal-title":"Rheumatology (Oxford)"},{"key":"2164_CR50","doi-asserted-by":"publisher","first-page":"e003792","DOI":"10.1161\/CIRCIMAGING.115.003792","volume":"9","author":"M Mukherjee","year":"2016","unstructured":"Mukherjee M, Chung SE, Ton VK, Tedford RJ, Hummers LK, Wigley FM, Abraham TP, Shah AA. Unique Abnormalities in Right Ventricular Longitudinal Strain in systemic sclerosis patients. Circ Cardiovasc Imaging. 2016;9:e003792. https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.003792.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2164_CR51","unstructured":"Mukherjee MMV, Tedford RJ, Shah AA, Hsu S, Damico RL, Kolb TM, Mathai SC. Hassoun P.M. Regional Heterogenity of the right ventricle in systemic sclerosis versus idiopathic pulmonary arterial hypertension. Eur Respir J. 2017."},{"key":"2164_CR52","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1164\/rccm.202204-0731OC","volume":"207","author":"HJ Hassan","year":"2023","unstructured":"Hassan HJ, Naranjo M, Ayoub N, Housten T, Hsu S, Balasubramanian A, Simpson CE, Damico RL, Mathai SC, Kolb TM, et al. Improved survival for patients with systemic sclerosis-associated pulmonary arterial hypertension: the Johns Hopkins Registry. Am J Respir Crit Care Med. 2023;207:312\u201322. https:\/\/doi.org\/10.1164\/rccm.202204-0731OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2164_CR53","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/2045893217700438","volume":"7","author":"KI Bourji","year":"2017","unstructured":"Bourji KI, Kelemen BW, Mathai SC, Damico RL, Kolb TM, Mercurio V, Cozzi F, Tedford RJ, Hassoun PM. Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction. Pulm Circ. 2017;7:409\u201320. https:\/\/doi.org\/10.1177\/2045893217700438.","journal-title":"Pulm Circ"},{"key":"2164_CR54","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/acr2.1037","volume":"1","author":"AH Tennoe","year":"2019","unstructured":"Tennoe AH, Murbraech K, Andreassen JC, Fretheim H, Midtvedt O, Garen T, Dalen H, Gude E, Andreassen A, Aakhus S, et al. Systolic dysfunction in systemic sclerosis: prevalence and prognostic implications. ACR Open Rheumatol. 2019;1:258\u201366. https:\/\/doi.org\/10.1002\/acr2.1037.","journal-title":"ACR Open Rheumatol"},{"key":"2164_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/ard.2008.103382","volume":"69","author":"Y Allanore","year":"2010","unstructured":"Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, Riemekasten G, Cozzi F, Beretta L, Derk CT, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis. 2010;69:218\u201321. https:\/\/doi.org\/10.1136\/ard.2008.103382.","journal-title":"Ann Rheum Dis"},{"key":"2164_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/eurjhf\/hfp198","volume":"12","author":"R Mizuno","year":"2010","unstructured":"Mizuno R, Fujimoto S, Saito Y, Nakamura S. Cardiac Raynaud\u2019s phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study. Eur J Heart Fail. 2010;12:268\u201375. https:\/\/doi.org\/10.1093\/eurjhf\/hfp198.","journal-title":"Eur J Heart Fail"},{"key":"2164_CR57","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.echo.2010.02.015","volume":"23","author":"H Geyer","year":"2010","unstructured":"Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23:351\u201369. https:\/\/doi.org\/10.1016\/j.echo.2010.02.015.","journal-title":"J Am Soc Echocardiogr"},{"key":"2164_CR58","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","volume":"43","author":"M Pieroni","year":"2014","unstructured":"Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M, De Luca G, Laria A, Meduri A, Bellocci F, et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum. 2014;43:526\u201335. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.07.006.","journal-title":"Semin Arthritis Rheum"},{"key":"2164_CR59","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1515\/rir-2024-0014","volume":"5","author":"J Werakiat","year":"2024","unstructured":"Werakiat J, Pussadhamma B, Mahakkanukrauh A, Suwannaroj S, Foocharoen C. Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: a cohort study. Rheumatol Immunol Res. 2024;5:107\u201316. https:\/\/doi.org\/10.1515\/rir-2024-0014.","journal-title":"Rheumatol Immunol Res"},{"key":"2164_CR60","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.humpath.2007.06.013","volume":"38","author":"TR Soong","year":"2007","unstructured":"Soong TR, Barouch LA, Champion HC, Wigley FM, Halushka MK. New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy\u2013a report of 2 cases. Hum Pathol. 2007;38:1858\u201363. https:\/\/doi.org\/10.1016\/j.humpath.2007.06.013.","journal-title":"Hum Pathol"},{"key":"2164_CR61","doi-asserted-by":"publisher","unstructured":"Cubero Salazar IM, Lancaster AC, Jani VP, Montovano MJ, Kauffman M, Weller A, Ambale-Venkatesh B, Zimmerman SL, Simpson CE, Kolb TM, et al. Poor cardiac output reserve in pulmonary arterial hypertension is associated with right ventricular stiffness and impaired interventricular dependence. Eur Respir J. 2024;64. https:\/\/doi.org\/10.1183\/13993003.00420-2024.","DOI":"10.1183\/13993003.00420-2024"},{"key":"2164_CR62","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1161\/circulationaha.123.064717","volume":"147","author":"V Jani","year":"2023","unstructured":"Jani V, Aslam MI, Fenwick AJ, Ma W, Gong H, Milburn G, Nissen D, Cubero Salazar IM, Hanselman O, Mukherjee M, et al. Right ventricular Sarcomere Contractile Depression and the role of thick filament activation in Human Heart failure with Pulmonary Hypertension. Circulation. 2023;147:1919\u201332. https:\/\/doi.org\/10.1161\/circulationaha.123.064717.","journal-title":"Circulation"},{"key":"2164_CR63","doi-asserted-by":"publisher","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","volume":"62","author":"A Vonk-Noordegraaf","year":"2013","unstructured":"Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013;62:D22\u201333. https:\/\/doi.org\/10.1016\/j.jacc.2013.10.027.","journal-title":"J Am Coll Cardiol"},{"key":"2164_CR64","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.semarthrit.2015.06.011","volume":"45","author":"M Hinchcliff","year":"2015","unstructured":"Hinchcliff M, Khanna S, Hsu VM, Lee J, Almagor O, Chang RW, Steen V, Chung L, Investigators P. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry. Semin Arthritis Rheum. 2015;45:309\u201314. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.011.","journal-title":"Semin Arthritis Rheum"},{"key":"2164_CR65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3899\/jrheum.090697","volume":"37","author":"AA Shah","year":"2010","unstructured":"Shah AA, Wigley FM, Hummers LK. Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol. 2010;37:98\u2013104. https:\/\/doi.org\/10.3899\/jrheum.090697.","journal-title":"J Rheumatol"},{"key":"2164_CR66","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/CIRCHEARTFAILURE.112.000008","volume":"6","author":"RJ Tedford","year":"2013","unstructured":"Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten-Harris T, Boyce D, Kelemen BW, Bacher AC, Shah AA, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013;6:953\u201363. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000008.","journal-title":"Circ Heart Fail"},{"key":"2164_CR67","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.22069","volume":"54","author":"MR Fisher","year":"2006","unstructured":"Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L, Krishnan JA, Wigley F, Hassoun PM. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum. 2006;54:3043\u201350. https:\/\/doi.org\/10.1002\/art.22069.","journal-title":"Arthritis Rheum"},{"key":"2164_CR68","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1161\/CIRCULATIONAHA.116.022082","volume":"133","author":"S Hsu","year":"2016","unstructured":"Hsu S, Houston BA, Tampakakis E, Bacher AC, Rhodes PS, Mathai SC, Damico RL, Kolb TM, Hummers LK, Shah AA, et al. Right ventricular Functional Reserve in Pulmonary arterial hypertension. Circulation. 2016;133:2413\u201322. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022082.","journal-title":"Circulation"},{"key":"2164_CR69","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/resp.13067","volume":"22","author":"MR Lammi","year":"2017","unstructured":"Lammi MR, Saketkoo LA, Gordon JK, Lauto P, Fagan K, Steen VD, Investigators P. Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: observations from the PHAROS cohort. Respirology. 2017;22:1386\u201392. https:\/\/doi.org\/10.1111\/resp.13067.","journal-title":"Respirology"},{"key":"2164_CR70","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.semarthrit.2018.10.010","volume":"48","author":"A Young","year":"2019","unstructured":"Young A, Nagaraja V, Basilious M, Habib M, Townsend W, Gladue H, Badesch D, Gibbs JSR, Gopalan D, Manes A, et al. Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension. Semin Arthritis Rheum. 2019;48:1059\u201367. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.010.","journal-title":"Semin Arthritis Rheum"},{"key":"2164_CR71","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/art.42791","volume":"76","author":"O Distler","year":"2024","unstructured":"Distler O, Bonderman D, Coghlan JG, Denton CP, Grunig E, Khanna D, McLaughlin VV, Muller-Ladner U, Pope JE, Vonk MC, et al. Performance of DETECT Pulmonary arterial hypertension Algorithm according to the hemodynamic definition of pulmonary arterial hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines. Arthritis Rheumatol. 2024;76:777\u201382. https:\/\/doi.org\/10.1002\/art.42791.","journal-title":"Arthritis Rheumatol"},{"key":"2164_CR72","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/imj.16468","volume":"54","author":"Z Brown","year":"2024","unstructured":"Brown Z, Morrisroe K, Hansen D, Stevens W, Proudman S, Teng GG, Low A, Nikpour M. Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension. Intern Med J. 2024;54:1561\u20136. https:\/\/doi.org\/10.1111\/imj.16468.","journal-title":"Intern Med J"},{"key":"2164_CR73","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3899\/jrheum.110512","volume":"38","author":"SC Mathai","year":"2011","unstructured":"Mathai SC, Sibley CT, Forfia PR, Mudd JO, Fisher MR, Tedford RJ, Lechtzin N, Boyce D, Hummers LK, Housten T, et al. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol. 2011;38:2410\u20138. https:\/\/doi.org\/10.3899\/jrheum.110512.","journal-title":"J Rheumatol"},{"key":"2164_CR74","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","volume":"174","author":"PR Forfia","year":"2006","unstructured":"Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, Chamera E, Corretti MC, Champion HC, Abraham TP, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034\u201341. https:\/\/doi.org\/10.1164\/rccm.200604-547OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2164_CR75","doi-asserted-by":"publisher","unstructured":"Mercurio V, Hassan HJ, Naranjo M, Cuomo A, Mazurek JA, Forfia PR, Balasubramanian A, Simpson CE, Damico RL, Kolb TM, et al. Risk stratification of patients with pulmonary arterial hypertension: the role of Echocardiography. J Clin Med. 2022;11. https:\/\/doi.org\/10.3390\/jcm11144034.","DOI":"10.3390\/jcm11144034"},{"key":"2164_CR76","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/circimaging.111.971465","volume":"5","author":"ML Haeck","year":"2012","unstructured":"Haeck ML, Scherptong RW, Marsan NA, Holman ER, Schalij MJ, Bax JJ, Vliegen HW, Delgado V. Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension. Circ Cardiovasc Imaging. 2012;5:628\u201336. https:\/\/doi.org\/10.1161\/circimaging.111.971465.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2164_CR77","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0735-1097(02)01744-8","volume":"39","author":"RJ Raymond","year":"2002","unstructured":"Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39:1214\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2164_CR78","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/ejechocard\/jeq011","volume":"11","author":"G Brierre","year":"2010","unstructured":"Brierre G, Blot-Souletie N, Degano B, T\u00eatu L, Bongard V, Carri\u00e9 D. New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension. Eur J Echocardiogr. 2010;11:516\u201322. https:\/\/doi.org\/10.1093\/ejechocard\/jeq011.","journal-title":"Eur J Echocardiogr"},{"key":"2164_CR79","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.201704-0789LE","volume":"197","author":"V Mercurio","year":"2017","unstructured":"Mercurio V, Mukherjee M, Tedford RJ, Zamanian RT, Khair RM, Sato T, Minai OA, Torres F, Girgis RE, Chin K, et al. Improvement in right ventricular strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma Pulmonary arterial hypertension. Am J Respir Crit Care Med. 2017;197:388\u201391. https:\/\/doi.org\/10.1164\/rccm.201704-0789LE.","journal-title":"Am J Respir Crit Care Med"},{"key":"2164_CR80","doi-asserted-by":"publisher","first-page":"e009047","DOI":"10.1161\/CIRCIMAGING.119.009047","volume":"12","author":"K Tello","year":"2019","unstructured":"Tello K, Wan J, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Mohajerani E, Seeger W, Herberg U, et al. Validation of the tricuspid annular plane systolic Excursion\/Systolic pulmonary artery pressure ratio for the Assessment of Right Ventricular-Arterial Coupling in severe pulmonary hypertension. Circ Cardiovasc Imaging. 2019;12:e009047. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.009047.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2164_CR81","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/ehjci\/jex133","volume":"19","author":"TM Gorter","year":"2018","unstructured":"Gorter TM, van Veldhuisen DJ, Voors AA, Hummel YM, Lam CSP, Berger RMF, van Melle JP, Hoendermis ES. Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension. Eur Heart J Cardiovasc Imaging. 2018;19:425\u201332. https:\/\/doi.org\/10.1093\/ehjci\/jex133.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2164_CR82","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ejhf.664","volume":"19","author":"S Ghio","year":"2017","unstructured":"Ghio S, Guazzi M, Scardovi AB, Klersy C, Clemenza F, Carluccio E, Temporelli PL, Rossi A, Faggiano P, Traversi E, et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. Eur J Heart Fail. 2017;19:873\u20139. https:\/\/doi.org\/10.1002\/ejhf.664.","journal-title":"Eur J Heart Fail"},{"key":"2164_CR83","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/echo.15432","volume":"39","author":"V Jani","year":"2022","unstructured":"Jani V, Kapoor K, Meyer J, Lu J, Goerlich E, Metkus TS, Madrazo JA, Michos E, Wu K, Bavaro N, et al. Unsupervised machine learning demonstrates the prognostic value of TAPSE\/PASP ratio among hospitalized patients with COVID-19. Echocardiography. 2022;39:1198\u2013208. https:\/\/doi.org\/10.1111\/echo.15432.","journal-title":"Echocardiography"},{"key":"2164_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2024.03.043","author":"VP Jani","year":"2024","unstructured":"Jani VP, Strom JB, Gami A, Beussink-Nelson L, Patel R, Michos ED, Shah SJ, Freed BH, Mukherjee M. Optimal method for assessing right ventricular to pulmonary arterial coupling and subclinical right ventricular dysfunction in older aged healthy adults: the multi-ethnic study of atherosclerosis. Am J Cardiol. 2024. https:\/\/doi.org\/10.1016\/j.amjcard.2024.03.043.","journal-title":"Am J Cardiol"},{"key":"2164_CR85","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.amjcard.2023.03.016","volume":"196","author":"M Mukherjee","year":"2023","unstructured":"Mukherjee M, Ogunmoroti O, Jani V, Kapoor K, Beussink-Nelson L, Freed BH, Hays AG, Shah SJ, Michos ED. Characteristics of right ventricular to pulmonary arterial Coupling and Association with Functional Status among older aged adults from the multi-ethnic study of atherosclerosis. Am J Cardiol. 2023;196:41\u201351. https:\/\/doi.org\/10.1016\/j.amjcard.2023.03.016.","journal-title":"Am J Cardiol"},{"key":"2164_CR86","first-page":"S42","volume":"21","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger TA Jr., Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003;21:S42\u201346.","journal-title":"Clin Exp Rheumatol"},{"key":"2164_CR87","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13075-022-02835-5","volume":"24","author":"M Mukherjee","year":"2022","unstructured":"Mukherjee M, Mercurio V, Balasubramanian A, Shah AA, Hsu S, Simpson CE, Damico R, Kolb TM, Hassoun PM, Mathai SC. Defining minimal detectable difference in echocardiographic measures of right ventricular function in systemic sclerosis. Arthritis Res Ther. 2022;24:146. https:\/\/doi.org\/10.1186\/s13075-022-02835-5.","journal-title":"Arthritis Res Ther"},{"key":"2164_CR88","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-021-02237-9","author":"M Mukherjee","year":"2021","unstructured":"Mukherjee M, Mercurio V, Hsu S, Mayer SA, Mathai SC, Hummers LK, Kass DA, Hassoun PM, Wigley FM, Tedford RJ, et al. Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis. Int J Cardiovasc Imaging. 2021. https:\/\/doi.org\/10.1007\/s10554-021-02237-9.","journal-title":"Int J Cardiovasc Imaging"},{"key":"2164_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2022.10.006","author":"J Lu","year":"2022","unstructured":"Lu J, Jani V, Mercurio V, Hsu S, Hummers LK, Wigley F, Hassoun PM, Mathai SC, Shah AA, Mukherjee M. Stress echocardiographic prediction of emerging pulmonary vascular disease in systemic sclerosis. J Am Soc Echocardiogr. 2022. https:\/\/doi.org\/10.1016\/j.echo.2022.10.006.","journal-title":"J Am Soc Echocardiogr"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02164-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02164-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02164-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:54:53Z","timestamp":1772096093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02164-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2164"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02164-w","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"20 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"3"}}